Navigation Links
Women With Heart Disease and Diabetes Less Likely to Receive Proper Care: Study

y had diabetes.

For example, women with diabetes were 19 percent less likely than men to have their cholesterol within recommended ranges if they were enrolled in Medicare and 16 percent less likely than men to have cholesterol with recommended ranges if enrolled in commercial health plans.

Other types of care women received less often than men included being prescribed ACE inhibitor drugs for chronic heart failure and receiving prescriptions for beta blocker drugs following a heart attack.

Women with diabetes in both Medicare and commercial health plans were more likely to have received eye exams than their male peers.

The disparities were found among women even though they generally see a doctor or other health care provider more often than men. The disparities also remained after researchers accounted for socioeconomic factors that may influence care.

"These were all insured people. They all had access to medical care and they were all diagnosed with these diseases," Bird said. "The disparities cannot be explained by a lack of patient reporting or not recognizing the symptoms of a disease."

Bird said that more research needs to be done to understand why there are gender differences in outpatient care.

"As we become a nation with an older population, the type of routine preventive care we studied will become even more important," Bird said. "Understanding these gender differences may allow us to improve care."

The RAND study is one of four published in the latest edition of Womens Health Issues reporting on studies that found gender disparities among patients treated in managed care settings.

"Taken together, these studies make a compelling case for routine assessment and reporting of selected quality indicators by gender," said Dr. Allen Fremont, the lead author of an accompanying editorial and co-author of the RAND study. Fremont is a na
'"/>




Page: 1 2 3

Related medicine news :

1. Women suffer from sexual dysfunction too
2. Women find difficulty in calling it Quits
3. Women recognise faces better
4. Women more susceptible to brain damage from ecstasy
5. Good News For Women With Gestational Diabetes
6. Unsatisfactory Grade On Womens Health Issues
7. Risk for Pregnant Women
8. Womens strong sense of smell
9. Women need to exercise more to prevent obesity
10. Women benefit from consuming fish
11. Women are at risk with raised cholesterol
Post Your Comments:
(Date:7/25/2008)...benefit ALS Therapy Alliance to be presented at Fe... WOONSOCKET, R.I., July 25 /PRNewswire/ -- CVS/pha... a record-breaking $4.4 million in just 21 days,th... ALS research. This is,the seventh year of the ann...more than $15 million for ALS research. This year,...
(Date:7/25/2008)... New program delivers immediate cost s...hour telephone access to language interpreters] t...ltilingual solutions. , W...reg; http://www.lle-inc.com/index.html [(Languag... of interpretation, translation, and language inst...
(Date:7/25/2008)... This donation will be used to facilit...ervices for children , Ha...ww.ivci.com ), a leading integrator of enterprise... video conferencing, telepresence, audio visual in...unced today that it has donated video conferencing...
(Date:7/24/2008)...N, July 24 /PRNewswire-USNewswire/ -- Speaker Nanc...ning in support of the Tom Lantos,and Henry J. Hyd..., and,Malaria Reauthorization Act of 2008. The bil...ouse this evening by a vote of 303 to 115 and will... "Today the House took an historic vote to pass l...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2
...birth do survive into adolescence, a study conduct...lly it is believed that virtually all children inf.... But doctors working in sub-Saharan Africa have b...dmitted in HIV clinics. Researchers from the Well...
...bs with the NHS in the last quarter of 2006.The to...as per official statistics//. The job-cuts may be ...take a toll on patient care. Most of the redunda... category. Nevertheless, for those who have lost t...
...es cause a bizarre but dangerous side effect -- sl...n (FDA) has warned. Those who take the pills co...y may have no memory of having taken a tablet at a...g phone calls or fixing and eating food even while...
...which was in use even in ancient civilizations, ...//hospital settings. Scientists of the NHS who a...ich are taking over many hospitals across U.K, are...erial properties of this metal to use. Selly Oaks...
Other Medicine News:Health News:Trial Run of Copper to Combat MRSA 2
(Date:7/23/2008)...erapy to Treat the Disease -, WAYNE, N.J. and EME...,Bayer HealthCare Pharmaceuticals and Onyx Pharmac... The New England Journal of Medicine published,res...(R) (sorafenib),tablets decreased the absolute ris...able hepatocellular carcinoma (HCC), or liver canc...
(Date:7/23/2008)... Have Greater Concentrations of,Stem Cells, ARLIN.../ -- Fat removed,from the lower abdomen and inner ...lent source of stem cells, with higher stem cell c...s a Brazilian-based study in August,s,Plastic and ...urnal of the,American Society of Plastic Surgeons ...
(Date:7/22/2008)...center 293-patient European, trial -, http://ww...YT, MONTREAL, July 22 / Cr...cryotherapy products to treat cardiac,arrhythmias,... from three,European study centers using the Compa... earlier today in the Journal of the American Coll...
(Date:7/22/2008)...ma Exhibits Excellent Drug-Like ...itiation of Phase II Clinical Trials -, RESEARCH ...x BioPharma,Inc., a clinical stage company develo... diseases of the central nervous system, today ann...TM) into Phase II trials for the,treatment of depr...
Breaking Medicine Technology:The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6Want a Reason to Love Your Lower Belly Fat? It's Rich in Stem Cells 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Novo Nordisk Settles With Pfizer On Patent Infringement Suit 8008 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 1CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 2CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 3CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 4CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 5CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 6CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End of Phase II Meeting with FDA 8003 7Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 1Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 2Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 3Kidney Patients Health Is Jeopardized by Proposed Medicare Changes 7998 4FDLI PEN co sponsor major conference on nanotechnology 1536 1FDLI PEN co sponsor major conference on nanotechnology 1536 2FDLI PEN co sponsor major conference on nanotechnology 1536 3
...est, Most Comprehensive Survey Provides New Benchm...June 21, 2007 /PRNewswire-USNewswire/ -- The,follo... -- First nationwide study of the prevalence of M... (MRSA), a virulent multi-drug resistant organism,...RSA prevalence study findings significantly exceed...
...TAIN VIEW, Calif., June 22, 2007 /PRNewswire/ -- M...ill present Phase 2,data from its Unit Dose Budeso...am at the World Asthma Meeting at the Lutfi Kirdar...key. , The oral and poster presentation entitled, ... formulation of budesonide for,nebulized delivery ...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2,Clinical Data at the World Asthma Meeting 2
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: